Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02776969 · ClinicalTrials.gov registry record
A Gene Hunting Study for Familial Papillary Thyroid Cancer
A clinical trial of Thyroid, sponsored by Ohio State University Comprehensive Cancer Center.
- Active
- Registry status
- 1,200
- Enrollment target
- 1
- Study location
NCT02776969: Active study of Thyroid, sponsored by Ohio State University Comprehensive Cancer Center.
NCT02776969 is a study of Thyroid that is active but no longer recruiting, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 1,200 participants, above the 104-participant average among 5 other Thyroid trials with a reported enrollment target (1054% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02776969, a study of Thyroid, is active but no longer recruiting, sponsored by Ohio State University Comprehensive Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 1,200 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this project is to identify genetic risk factors associated with familial papillary thyroid carcinoma (PTC). Papillary thyroid cancer is a type of cancer that shows high heritability. However, the specific genetic factors that cause an increased risk have been elusive.
Primary Outcome
Variants will be assessed for segregation within families, expression in the normal thyroid and/or thyroid cancer, and functional significance
Conditions Studied
Study Locations (1)
Ohio
- Ohio State University Comprehensive Cancer Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 1998-08-05 |
| Est. Completion | 2026-12 |
What the registry record for NCT02776969 still lists
NCT02776969 is an observational study that tracks outcomes without assigning an intervention. Its 1,200 participants enrollment target places it among the larger protocols in the corpus, above the 104-participant average among 5 other Thyroid trials with a reported enrollment target (1054% higher).
The record links to 1 condition, with Thyroid appearing as the primary indexed condition, and to 0 interventions.
NCT02776969 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT02776969 about?
NCT02776969 is a clinical study titled "A Gene Hunting Study for Familial Papillary Thyroid Cancer". The aim of this project is to identify genetic risk factors associated with familial papillary thyroid carcinoma (PTC). Papillary thyroid cancer is a type of cancer that shows high heritability. However, the specific genetic factors that cause an increased risk have been elusive.
What is the current status of trial NCT02776969?
This trial is currently active not recruiting. The enrollment target is 1,200 participants. The study started on 1998-08-05. Estimated completion is 2026-12.
What conditions does trial NCT02776969 study?
This clinical trial studies the following conditions: Thyroid.
Who is sponsoring clinical trial NCT02776969?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02776969 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thyroid
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Treatment of ARDS With Instilled T3
RECRUITING · Phase 2
-
Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors
RECRUITING
-
A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer
RECRUITING
-
Laser Ablation of Papillary Thyroid Microcarcinoma
ACTIVE NOT RECRUITING · Phase 2
-
Randomized Trial Comparing Performance of Molecular Markers for Indeterminate Thyroid Nodules
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
- NCT00477100 · 1,200 participants
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- NCT01209000 · 1,200 participants
Nephrotic Syndrome Study Network
- NCT01944332 · 1,200 participants · NA
Gamete Treatment to Correct Fertilization Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI